Fluorescence correlation spectroscopy reveals a cooperative unfolding of monomeric amyloid-β 42 with a low Gibbs free energy

Scientific Reports
Mario SchneiderDieter Willbold

Abstract

The amyloid-beta peptide (Aβ) plays a major role in the progression of Alzheimer's disease. Due to its high toxicity, the 42 amino acid long isoform Aβ42 has become of considerable interest. The Aβ42 monomer is prone to aggregation down to the nanomolar range which makes conventional structural methods such as NMR or X-ray crystallography infeasible. Conformational information, however, will be helpful to understand the different aggregation pathways reported in the literature and will allow to identify potential conditions that favour aggregation-incompetent conformations. In this study, we applied fluorescence correlation spectroscopy (FCS) to investigate the unfolding of Alexa Fluor 488 labelled monomeric Aβ42 using guanidine hydrochloride as a denaturant. We show that our Aβ42 pre-treatment and the low-nanomolar concentrations, typically used for FCS measurements, strongly favour the presence of monomers. Our results reveal that there is an unfolding/folding behaviour of monomeric Aβ42. The existence of a cooperative unfolding curve suggests the presence of structural elements with a Gibbs free energy of unfolding of about 2.8 kcal/mol.

References

May 1, 1975·CRC Critical Reviews in Biochemistry·C N Pace
Jan 1, 1972·Methods in Enzymology·Y Nozaki
Feb 27, 1999·Biophysical Journal·U MesethH Vogel
Jul 2, 1999·Biophysical Journal·Y ChenE Gratton
Dec 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gal BitanDavid B Teplow
Feb 13, 2003·European Journal of Biochemistry·David FrostAvijit Chakrabartty
Oct 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sheh-Yi SheuE W Schlag
Dec 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yan ChenJoachim D Müller
Nov 24, 2004·Biophysical Journal·Krishnananda ChattopadhyayCarl Frieden
Jun 3, 2005·Protein Science : a Publication of the Protein Society·Noel D LazoDavid B Teplow
Nov 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Thorsten LührsRoland Riek
Feb 3, 2007·Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry·Thomas DertingerJörg Enderlein
Apr 3, 2007·Journal of Molecular Biology·Nikolaos G SgourakisAngel E Garcia
Jun 20, 2007·Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry·Jörg Enderlein
Jan 7, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chun-Lun NiYun-Ru Chen
Feb 26, 2011·The Journal of Biological Chemistry·Suman NagSudipta Maiti
Sep 29, 2011·The Journal of Physical Chemistry. B·Dibyendu Kumar SasmalKankan Bhattacharyya
Apr 11, 2012·Angewandte Chemie·Alexander K BuellMark E Welland
Apr 29, 2014·Biochemical and Biophysical Research Communications·Judith J MittagJennifer J McManus
Feb 13, 2016·Scientific Reports·Linh TranTâp Ha-Duong

❮ Previous
Next ❯

Citations

Mar 24, 2018·International Journal of Molecular Sciences·Akira Kitamura, Masataka Kinjo
Aug 31, 2021·RSC Chemical Biology·Jannik Bruun LarsenThomas Lars Andresen

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear
X-ray
fluorescence correlation spectroscopy
FCS
size exclusion chromatography
circular dichroism

Software Mentioned

Origin
MATLAB

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.